SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-244709
Filing Date
2021-08-12
Accepted
2021-08-12 16:19:06
Documents
15
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d212585d8k.htm   iXBRL 8-K 26990
2 EX-99.1 d212585dex991.htm EX-99.1 73270
7 GRAPHIC g212585sp03.jpg GRAPHIC 10048
  Complete submission text file 0001193125-21-244709.txt   287644

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pana-20210812.xsd EX-101.SCH 3971
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pana-20210812_def.xml EX-101.DEF 14357
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pana-20210812_lab.xml EX-101.LAB 23788
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pana-20210812_pre.xml EX-101.PRE 15391
8 EXTRACTED XBRL INSTANCE DOCUMENT d212585d8k_htm.xml XML 5612
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 211167844
SIC: 2834 Pharmaceutical Preparations